Abstract
CTLA-4 is a crucial immune regulator that mediates both negative co-stimulation signals to T cells, and regulatory T (Tr) cell extrinsic control of effector responses. We present evidence supporting a novel mechanism for this extrinsic suppression, executed by the alternatively spliced soluble CTLA-4 isoform (sCTLA-4). Analyses of human T cells in vitro show that sCTLA-4 secretion can be increased during responses, and has potent inhibitory properties, since isoform-specific blockade of its activity significantly increased antigen-driven proliferation and cytokine (interferon-¿, IL-17) secretion. Tr cells were demonstrated to be a prominent source of sCTLA-4, which contributed to suppression in vitro when their numbers were limiting. The soluble isoform was also produced by, and inhibited, murine T cells responding to antigen in vitro, and blockade of its activity in vivo protected against metastatic spread of melanoma in mice. We conclude that sCTLA-4 is an important immune regulator, responsible for at least some of the inhibitory effects previously ascribed to the membrane-bound isoform. These results suggest that the immune system exploits the different CTLA-4 isoforms for either intrinsic or extrinsic regulation of T cell activity.
Original language | English |
---|---|
Pages (from-to) | 1274-1285 |
Number of pages | 12 |
Journal | European Journal of Immunology |
Volume | 43 |
Issue number | 5 |
Early online date | 6 Mar 2013 |
DOIs | |
Publication status | Published - May 2013 |
Keywords
- costimulation
- regulatory cells
- CTLA-4 polymorphisms
- CD4+ T cells
- costimulatory molecules
- immune regulation
- Treg cells